- link Copy Url
- [  Share on twitter ](https://twitter.com/intent/tweet?text=Sanofi Rises 2 Positions in the 2016 Access to Medicine Index https://www.3blmedia.com/markdownify/node/77234?absolute=1&via=3blnews "link to 3 B L Media's Twitter")
- [  Share on linkedin ](https://www.linkedin.com/shareArticle?mini=true&url=https://www.3blmedia.com/markdownify/node/77234?absolute=1 "link to 3 B L Media's Linkedin")
- [  Share on facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.3blmedia.com/markdownify/node/77234?absolute=1 "link to 3 B L Media's Facebook")
- [ email Share via email ](mailto:?subject=Sanofi Rises 2 Positions in the 2016 Access to Medicine Index&body=ESG News from Sanofi https://www.3blmedia.com/markdownify/node/77234?absolute=1 "Share via email")
 
 

 [Research, Reports & Publications](/CSR-News/research-reports-publications)

 # Sanofi Rises 2 Positions in the 2016 Access to Medicine Index

 


 

 Dec 7, 2016 1:40 PM ET

  Campaign:  [Sanofi Global](/news/campaign/sanofi-global)  ![](https://3blaws.s3.amazonaws.com/styles/carousel_2x/s3/images/Logo_ATM.jpg) 

In 2016, Sanofi has risen 2 positions in the Access To Medicine (ATM) Index, from 8th to 6th rank. The ATM Index analyses the top 20 research-based pharmaceutical companies on how they make medicines, vaccines and diagnostics more accessible in low- and middle-income countries.

**Sanofi’s performance is well recognized this year in the two main areas, which represent 45% of the overall score and are major enablers of access:**

**Research & Development:**

Our performance in R&D is due to a larger relevant pipeline with 28 relevant R&D projects, including several new fixed-dose combinations for treating tuberculosis and a paediatric formulation of primaquine for malaria, to high standards of transparency regarding our clinical trial data and to the sharing of intellectual property with several partners in order to accelerate research in tuberculosis, malaria and neglected tropical diseases.

**Pricing, Manufacturing & Distribution:**

Sanofi improved in equitable pricing. We are among the 3 companies having the best performance to meet the key criteria set by the Index for pricing strategies. Besides, we are the company leader marketing the most essential medicines and vaccines (WHO Model Essential Medicines List).

The ATM Index also recognizes our innovative approach in the field of “climate change and health” still confirmed these days with [our participation to COP22 at Marrakech](http://en.sanofi.com/csr/news/2016-11-07-COP22-sanofi-extends-its-commitment.aspx "Access to the news about COP22: Sanofi extends its commitment against the effects of climate change"). For more than 2 years now, we have been investigating health- and access-related issues linked to climate change.

Finally, Sanofi is the biggest riser in the area of marketing practices and compliance, climbing 13 places into the top 5. The ATM index notably emphasizes our above-average transparency and our certification system that allows us to regularly test and update the skills of our sales agents.

[Learn more about the ATM Index here.](http://accesstomedicineindex.org/ "Access to accesstomedicineindex.org website")



 

 

 

 

 

 

 

 [![](/sites/default/files/Clients/Logo_rapport_2_0.png)](/profiles/sanofi)

 



 

### More from Sanofi

###### [Perseverance in Rare Diseases at Sanofi](/news/perseverance-rare-diseases-sanofi)

 Mar 17, 2020 11:35 AM ET

  



###### [Meet Dale, Breast Cancer Patient & Advocate](/news/meet-dale-breast-cancer-patient-advocate)

 Mar 10, 2020 10:35 AM ET

  



###### [Sanofi US Named Top Company by the National Association for Female Executives](/news/sanofi-us-named-top-company-national-association-female-executives)

 Mar 4, 2020 4:50 PM ET

  



###### [As Cancer in Older People Increases, so Do the Challenges to Help Them Live Longer, Fuller Lives](/news/cancer-older-people-increases-so-do-challenges-help-them-live-longer-fuller-lives)

 Mar 4, 2020 11:40 AM ET

  



###### [Transforming Humanitarian Aid in Hemophilia](/news/transforming-humanitarian-aid-hemophilia)

 Dec 23, 2019 9:35 AM ET

  



###### [27 Years of Humanitarian Programs in Vietnam](/news/27-years-humanitarian-programs-vietnam)

 Dec 20, 2019 9:00 AM ET

  



###### [Real-Life Experience Makes This Mom a Vaccine Champion](/news/real-life-experience-makes-mom-vaccine-champion)

 Dec 18, 2019 9:00 AM ET

  



###### [Listen: Sanofi's Elaine O’Hara Joins the Women In Government Podcast to Discuss Vaccines](/news/listen-sanofis-elaine-ohara-joins-women-government-podcast-discuss-vaccines)

 Dec 6, 2019 3:30 PM ET